BofA & CITI: $VRTX ✌️ Quick 55% Returns🚀 🔹Buy rating PT: $325 💪 🔹Bull Case Still Strong 🔹VX-864 Back Up Drug on Trial 🔹VX-864 Top-Line 🔹CF franchise alone more than justifies current price 🔹More high impact catalysts coming soon 🔹AATD program is still intact 🔹ARK GROUP LOADED 67K SHARES👀 $SPY $DJIA
  • 5
5 Likes